Actuate Therapeutics (ACTU) Liabilities and Shareholders Equity (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Liabilities and Shareholders Equity of $14.0 million for Q4 2025, up 50.62% year-over-year from $9.3 million in Q4 2024, and down 20.76% quarter-over-quarter from $17.7 million in Q3 2025.
Actuate Therapeutics (ACTU) Liabilities and Shareholders Equity (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $14.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 50.62% year-over-year to $14.0 million; the TTM figure through Dec 2025 stood at $43.2 million (up 70.68% YoY), while the FY2025 annual figure was $14.0 million, up 50.62% from the prior year.
- Liabilities and Shareholders Equity declined to $14.0 million in Q4 2025 per ACTU's latest filing, from $17.7 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $17.7 million in Q3 2025 and bottomed at $1.7 million in Q2 2024.
- Historically, Liabilities and Shareholders Equity has averaged $8.9 million across 3 years, with a median of $8.1 million in 2024.
- On a YoY basis, Liabilities and Shareholders Equity climbed as much as 302.63% in 2025 and fell as far as 24.2% in 2025.
- Actuate Therapeutics' Liabilities and Shareholders Equity stood at $3.0 million in 2023, then jumped by 211.07% to $9.3 million in 2024, then surged by 50.62% to $14.0 million in 2025.
- Business Quant data shows ACTU's Liabilities and Shareholders Equity at $14.0 million in Q4 2025, $17.7 million in Q3 2025, and $7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | 5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.04 Mn |
| Sep 30, 2025 | 17.71 Mn |
| Jun 30, 2025 | 6.97 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 9.32 Mn |
| Sep 30, 2024 | 14.26 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Dec 31, 2023 | 3.00 Mn |